Healthcare - Biotechnology - NASDAQ - US
$ 44.83
-3.9 %
$ 1.71 B
Market Cap
-10.05
P/E
Price Target
Average
38.30%
Revenue Forecast
Estimate
162.80%
EBIT
Estimate
27.21%
Net Income
Estimate
36.89%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Tarsus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for TARS of $62 , with forecasts ranging from a low of $61 to a high of $63 .
TARS Lowest Price Target
Wall Street Target
61 USD
36.07%
TARS Average Price Target
Wall Street Target
62 USD
38.30%
TARS Highest Price Target
Wall Street Target
63 USD
40.53%
REVENUE FORECAST
Revenue Forecast Chart TARS
EBIT FORECAST
EBIT Forecast Chart TARS
NET INCOME FORECAST
Net Income Chart TARS